Vectura Group

Vectura's product development, formulation and drug delivery expertise is centred around developing inhaled products to address unmet needs in airways diseases. Vectura has established development collaborations, joint ventures and license agreements with several global pharmaceutical and biotechnology companies. Vectura is based in the UK, with headquarters in Chippenham, Wiltshire and operates in Cambridge (UK), Germany and a US operations office near Boston MA.
Chippenham, GB
Size (employees)
270 (est)+12%
Vectura Group is headquartered in Chippenham, GB

Vectura Group Office Locations

Vectura Group has an office in Chippenham
Chippenham, GB (HQ)
Prospect West Bumpers Way

Vectura Group Metrics

Vectura Group Financial Metrics

Revenue (2016)

£72 m

Revenue growth (2015-16), %


Gross profit

£68.7 m

Gross profit margin (2016), %


Market capitalization (22-Mar-2017)

£926.4 m

Closing share price (22-Mar-2017)

Vectura Group's current market capitalization is £926.4 m.
Vectura Group's revenue was reported to be £72 m in FY, 2016 which is a 24.1% increase from the previous period.
FY, 2014FY, 2015FY, 2016


£36.5 m£58 m£72 m

Revenue growth, %


Cost of goods sold

£1 m£2.4 m£3.3 m

Gross profit

£35.5 m£55.6 m£68.7 m

Gross profit Margin, %


Operating expense total

£41.7 m£62.6 m£73.8 m

Vectura Group Market Value History

Vectura Group Job Categories

Vectura Group News

Vectura Group Company Life

You may also be interested in